US$ 29.14
foxo4 dri senolytic peptide 2023 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOX04-DRI - Apollo Peptide Sciences
Description
Petersburg Institute of Bioregulation and Gerontology, led by Vladimir Khavinson until his death in 2024

Cell 164, 603615

In some embodiments, the otic formulation or composition comprises about 17% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof

Bouattour M, Raymond E, Qin S, Cheng AL, Stammberger U, Locatelli G, et al
